These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20816833)

  • 21. Onset of effect of budesonide and formoterol administered via one pressurized metered-dose inhaler in patients with asthma previously treated with inhaled corticosteroids.
    Kaiser H; Parasuraman B; Boggs R; Miller CJ; Leidy NK; O'Dowd L
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):295-303. PubMed ID: 18814453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-inflammatory effects of combined budesonide/formoterol in COPD exacerbations.
    Bathoorn E; Liesker JJ; Postma DS; Boorsma M; Bondesson E; Koëter GH; Kauffman HF; van Oosterhout AJ; Kerstjens HA
    COPD; 2008 Oct; 5(5):282-90. PubMed ID: 18972276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchodilator efficacy of tiotropium-formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD.
    Salvi S; Brashier B; Gothi D; Karkhanis V; Madas S; Gogtay J; Joshi J
    Pulm Pharmacol Ther; 2014 Feb; 27(1):90-5. PubMed ID: 23752057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidetector-row computed tomography assessment of adding budesonide/formoterol to tiotropium in patients with chronic obstructive pulmonary disease.
    Yasui H; Inui N; Furuhashi K; Nakamura Y; Uto T; Sato J; Yasuda K; Takehara Y; Suda T; Chida K
    Pulm Pharmacol Ther; 2013 Jun; 26(3):336-41. PubMed ID: 23340058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of formoterol with or without budesonide in repeated low-dose allergen challenge.
    Dahlén B; Lantz AS; Ihre E; Skedinger M; Henriksson E; Jörgensen L; Ekström T; Dahlén SE; Larsson K
    Eur Respir J; 2009 Apr; 33(4):747-53. PubMed ID: 19129280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung deposition and efficacy of inhaled formoterol in patients with moderate to severe COPD.
    Derom E; Strandgården K; Schelfhout V; Borgström L; Pauwels R
    Respir Med; 2007 Sep; 101(9):1931-41. PubMed ID: 17544264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.
    Bodzenta-Lukaszyk A; Buhl R; Balint B; Lomax M; Spooner K; Dissanayake S
    J Asthma; 2012 Dec; 49(10):1060-70. PubMed ID: 23102189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and tolerability of high-dose budesonide/formoterol via Turbuhaler® in Japanese patients with asthma: a randomized, double-blind, crossover, active comparator-controlled, phase III study.
    Saito T; Hasunuma T
    Clin Drug Investig; 2012 Jan; 32(1):51-61. PubMed ID: 22024920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of budesonide/formoterol more effective than fluticasone/salmeterol in preventing exacerbations in chronic obstructive pulmonary disease: the PATHOS study.
    Larsson K; Janson C; Lisspers K; Jørgensen L; Stratelis G; Telg G; Ställberg B; Johansson G
    J Intern Med; 2013 Jun; 273(6):584-94. PubMed ID: 23495860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
    Miller CJ; Senn S; Mezzanotte WS
    Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the acute effect of tiotropium versus a combination therapy with single inhaler budesonide/formoterol on the degree of resting pulmonary hyperinflation.
    Santus P; Centanni S; Verga M; Di Marco F; Matera MG; Cazzola M
    Respir Med; 2006 Jul; 100(7):1277-81. PubMed ID: 16337781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD.
    Morgan AR; Parker GJ; Roberts C; Buonaccorsi GA; Maguire NC; Hubbard Cristinacce PL; Singh D; Vestbo J; Bjermer L; Jögi J; Taib Z; Sarv J; Bruijnzeel PL; Olsson LE; Bondesson E; Nihlén U; McGrath DM; Young SS; Waterton JC; Nordenmark LH
    Eur J Radiol; 2014 Nov; 83(11):2093-101. PubMed ID: 25176287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pulmonary and extra-pulmonary effects of high-dose formoterol in COPD: a comparison with salbutamol.
    Goldkorn A; Diotto P; Burgess C; Weatherall M; Holt S; Beasley R; Siebers R
    Respirology; 2004 Mar; 9(1):102-8. PubMed ID: 14982610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Onset of action following formoterol Turbuhaler and salbutamol pMDI in reversible chronic airway obstruction.
    Cazzola M; Grella E; Matera MG; Mazzarella G; Marsico SA
    Pulm Pharmacol Ther; 2002; 15(2):97-102. PubMed ID: 12090782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients.
    Singh D; Piccinno A; Borrill Z; Poli G; Acerbi D; Meuleners L; Woodcock A
    Pulm Pharmacol Ther; 2008; 21(3):551-7. PubMed ID: 18321744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doppler echocardiographic assessment of the effects of inhaled long-acting beta2-agonists on pulmonary artery pressure in COPD patients.
    Cazzola M; Mantero A; Santus P; Carlucci P; Mondoni M; Bosotti L; Centanni S
    Pulm Pharmacol Ther; 2007; 20(3):258-64. PubMed ID: 16600647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of inhaled budesonide and formoterol in combination and alone when given directly after allergen challenge.
    Duong M; Gauvreau G; Watson R; Obminski G; Strinich T; Evans M; Howie K; Killian K; O'Byrne PM
    J Allergy Clin Immunol; 2007 Feb; 119(2):322-7. PubMed ID: 17141859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of basic therapy on clinical symptoms, quality of life and systemic inflammation in patients with chronic obstructive pulmonary disease].
    Baranova II; Leshchenko IV
    Klin Med (Mosk); 2013; 91(12):21-5. PubMed ID: 25702425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler.
    Masoli M; Williams M; Weatherall M; Beasley R
    Respir Med; 2006 Jan; 100(1):20-5. PubMed ID: 15936933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma.
    Tal A; Simon G; Vermeulen JH; Petru V; Cobos N; Everard ML; de Boeck K
    Pediatr Pulmonol; 2002 Nov; 34(5):342-50. PubMed ID: 12357478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.